CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,320,469
- in 18 filings, $12.5M under 10b5-1 plans
Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blum Robert I −$9.7M President & CEO sold 34% of stake
- Malik Fady Ibraham −$1.3M EVP Research & Development sold 12% of stake
- Hessekiel Jeffrey −$795K Chief Legal & Admin Officer sold 14% of stake
- Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
- PARSHALL B LYNNE −$631K Director sold 63% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-13 | Blum Robert I President & CEO | Sale 10b5-1 | −12,500 | $34.90 | $436K | 441,417 |
| 2023-09-13 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −12,500 | 243,494 | ||
| 2023-08-25 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +2,500 | $6.67 | $17K | 443,917 |
| 2023-08-25 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +10,000 | $7.96 | $80K | 453,917 |
| 2023-08-25 | Blum Robert I President & CEO | Sale 10b5-1 | −12,500 | $33.99 | $425K | 441,417 |
| 2023-08-25 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −2,500 | 255,994 | ||
| 2023-08-25 | Blum Robert I President & CEO | Exercise or conversion · Incentive Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2023-08-21 | WIERENGA WENDALL Director | Exercise or conversion 10b5-1 | +6,020 | $6.72 | $40K | 24,225 |
| 2023-08-21 | WIERENGA WENDALL Director | Sale 10b5-1 | −6,020 | $32.02 | $193K | 18,205 |
| 2023-08-21 | WIERENGA WENDALL Director | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −6,020 | 0 | ||
| 2023-08-11 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +11,708 | $9.65 | $113K | 453,125 |
| 2023-08-11 | Blum Robert I President & CEO | Sale 10b5-1 | −11,708 | $32.37 | $379K | 441,417 |
| 2023-08-11 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +792 | $7.96 | $6K | 442,209 |
| 2023-08-11 | Blum Robert I President & CEO | Sale 10b5-1 | −792 | $32.37 | $26K | 441,417 |
| 2023-08-11 | Blum Robert I President & CEO | Exercise or conversion · Incentive Stock Option (Right to Buy) 10b5-1 | −11,708 | 0 | ||
| 2023-08-11 | Blum Robert I President & CEO | Exercise or conversion · Incentive Stock Option (Right to Buy) 10b5-1 | −792 | 10,000 | ||
| 2023-08-10 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −2,500 | $31.70 | $79K | 158,164 |
| 2023-08-01 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +10,691 | $9.65 | $103K | 452,108 |
| 2023-08-01 | Blum Robert I President & CEO | Sale 10b5-1 | −10,691 | $32.63 | $349K | 441,417 |
| 2023-08-01 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +1,809 | $9.65 | $17K | 443,226 |
Page 39 of 45 · 885 trades